Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 12, 2022

BUY
$1.46 - $2.48 $3,650 - $6,200
2,500 Added 11.74%
23,800 $170,000
Q4 2021

Feb 14, 2022

SELL
$2.34 - $5.31 $14,508 - $32,922
-6,200 Reduced 22.55%
21,300 $137,000
Q3 2021

Nov 10, 2021

BUY
$1.89 - $8.53 $51,975 - $234,574
27,500 New
27,500 $96,000

Others Institutions Holding CRVS

About Corvus Pharmaceuticals, Inc.


  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $223M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.